| Literature DB >> 30289898 |
Ana Basto-Abreu1, Ariela Braverman-Bronstein1, Dalia Camacho-García-Formentí1, Rodrigo Zepeda-Tello1, Barry M Popkin2, Juan Rivera-Dommarco3, Mauricio Hernández-Ávila4, Tonatiuh Barrientos-Gutiérrez1.
Abstract
BACKGROUND: Several strategies have been proposed to reduce the intake of added sugars in the population. In Mexico, a 10% sugar-sweetened beverages (SSBs) tax was implemented in 2014, and the implementation of other nutritional policies, such as product reformulation to reduce added sugars, is under discussion. WHO recommends that all individuals consume less than 10% of their total energy intake (TEI) from added sugars. We propose gradually reducing added sugars in SSBs to achieve an average 10% consumption of added sugars in the Mexican population over 10 years and to estimate the expected impact of reformulation in adult body weight and obesity. METHODS ANDEntities:
Mesh:
Substances:
Year: 2018 PMID: 30289898 PMCID: PMC6173390 DOI: 10.1371/journal.pmed.1002664
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Sample characteristics, added-sugar intake (total and from SSBs) in and their contribution to the %TEI for the adult population in Mexico before regulation.
| Proportion of individuals in the sample (%) | Total added-sugar intake (kcal/day) (95% CI) | %TEI | Added-sugar intake from SSBs (kcal/day) (95% CI) | %TEI | |
|---|---|---|---|---|---|
| 244.9 (232.9–256.9) | 12.6 | 101.1 (93.3–109.0) | 5.1 | ||
| Male | 47.7 | 278.9 (259.9–297.9) | 12.9 | 128.0 (115.4–140.6) | 6.1 |
| Female | 52.3 | 213.9 (199.6–228.2) | 12.2 | 76.7 (67.4–86.0) | 4.2 |
| 20–39 | 44.6 | 285.7 (264.6–306.8) | 13.8 | 130.8 (117.5–144.2) | 6.4 |
| 40–59 | 36.8 | 235.7 (217.4–254.1) | 12.2 | 90.3 (78.1–102.4) | 4.5 |
| 60+ | 18.6 | 165.2 (148.2–182.2) | 10.3 | 51.4 (39.3–63.5) | 3.2 |
| Low | 29.7 | 213.1 (196.0–230.2) | 11.3 | 84.5 (71.8–97.2) | 4.5 |
| Middle | 30.1 | 255.0 (233.1–277.0) | 12.7 | 118.0 (102.6–133.3) | 5.7 |
| High | 40.2 | 260.7 (239.3–282.2) | 13.4 | 100.8 (87.6–114.0) | 5.2 |
Abbreviations: %TEI, percent of total energy intake; SES, socioeconomic status; SSB, sugar-sweetened beverage.
Predicted reduction in added sugars, energy intake, body weight, and BMI from a 50% gradual reduction of added sugars to SSBs, considering 43% compensation after 12 years.
| Added sugars (kcal/day) (95% CI) | Energy intake | Weight (kg) (95% CI) | BMI (kg/m2) (95% CI) | |
|---|---|---|---|---|
| −50.6 (−54.5 to −46.6) | −28.8 (−31.1 to −26.6) | −1.3 (−1.4 to −1.2) | −0.5 (−0.6 to −0.5) | |
| Male | −64.0 (−70.3 to −57.7) | −36.5 (−40.1 to −32.9) | −1.6 (−1.7 to −1.4) | −0.6 (−0.6 to −0.5) |
| Female | −38.3 (−43.0 to −33.7) | −21.8 (−24.5 to −19.2) | −1.1 (−1.2 to −0.9) | −0.5 (−0.5 to −0.4) |
| 20–39 | −65.4 (−72.1 to −58.7) | −37.3 (−41.1 to −33.5) | −1.6 (−1.8 to −1.5) | −0.6 (−0.7 to −0.6) |
| 40–59 | −45.1 (−51.2 to −39.1) | −25.7 (−29.2 to −22.3) | −1.2 (−1.4 to −1.1) | −0.5 (−0.6 to −0.4) |
| 60+ | −25.7 (−31.8 to −19.7) | −14.7 (−18.1 to −11.2) | −0.7 (−0.9 to −0.5) | −0.3 (−0.3 to −0.2) |
| Low | −42.2 (−48.6 to −35.9) | −24.1 (−27.7 to −20.5) | −1.1 (−1.2 to −0.9) | −0.4 (−0.5 to −0.4) |
| Middle | −59.0 (−66.7 to −51.3) | −33.6 (−38.0 to −29.2) | −1.5 (−1.7 to −1.3) | −0.6 (−0.7 to −0.5) |
| High | −50.4 (−57.0 to −43.8) | −28.7 (−32.5 to −25.0) | −1.3 (−1.5 to −1.2) | −0.5 (−0.6 to −0.4) |
*Net energetic change assuming 43% compensation for sources other than added sugars.
Abbreviations: BMI, body mass index; SES, socioeconomic status; SSB, sugar-sweetened beverage.
Predicted change in absolute and relative prevalence and absolute number of individuals for normal, overweight, and obesity after 12 years of the implementation of a 50% gradual reduction of added sugar in SSBs, considering a 43% compensation (data projected to year 2032).
| Baseline prevalence (%; 95% CI) | Change in prevalence (absolute pp; 95% CI) | Percent change in prevalence (% baseline; 95% CI) | Change in number of individuals (in millions; 95% CI) | ||
|---|---|---|---|---|---|
| Normal | 30.4 (27.9 to 33.1) | 3.8 (2.8 to 4.9) | 12.6 (9.0 to 16.3) | 3.5 (2.6 to 4.5) | |
| Overweight | 38.7 (36.1 to 41.4) | 0.0 (−1.6 to 1.7) | 0.0 (−4.2 to 4.3) | 0.0 (−1.5 to 1.5) | |
| Obesity | 30.9 (28.5 to 33.3) | −3.9 (−5.1 to −2.6) | −12.5 (−16.2 to −8.8) | −3.5 (−4.7 to −2.4) | |
| Male | Normal | 36.4 (32.3 to 40.7) | 5.0 (3.5 to 6.5) | 13.7 (9.0 to 18.3) | 2.2 (1.5 to 2.8) |
| Overweight | 39.5 (35.4 to 43.7) | −1.0 (−3.5 to 1.4) | −2.6 (−8.7 to 3.6) | −0.4 (−1.5 to 0.6) | |
| Obesity | 24.1 (20.9 to 27.7) | −4.0 (−5.8 to −2.1) | −16.4 (−23.4 to −9.4) | −1.7 (−2.5 to −0.9) | |
| Female | Normal | 25.0 (22.2 to 28.0) | 2.8 (1.5 to 4.2) | 11.3 (5.6 to 17.0) | 1.4 (0.7 to 2.0) |
| Overweight | 38.0 (34.4 to 41.7) | 1.0 (−1.2 to 3.1) | 2.5 (−3.3 to 8.3) | 0.5 (−0.6 to 1.5) | |
| Obesity | 37.0 (33.7 to 40.4) | −3.8 (−5.4 to −2.2) | −10.2 (−14.3 to −6.1) | −1.8 (−2.6 to −1.1) | |
| 20–39 | Normal | 39.4 (35.4 to 43.6) | 4.9 (3.0 to 6.9) | 12.5 (7.2 to 17.9) | 2.0 (1.2 to 2.8) |
| Overweight | 35.2 (31.2 to 39.5) | −0.3 (−3.1 to 2.6) | −0.7 (−8.7 to 7.3) | −0.1 (−1.3 to 1.1) | |
| Obesity | 25.3 (22.2 to 28.8) | −4.7 (−6.6 to −2.8) | −18.5 (−25.5 to −11.5) | −1.9 (−2.7 to −1.1) | |
| 40–59 | Normal | 19.1 (15.9 to 22.9) | 3.6 (2.1 to 5.1) | 18.8 (9.9 to 27.6) | 1.2 (0.7 to 1.7) |
| Overweight | 41.2 (36.8 to 45.7) | 0.5 (−2.2 to 3.3) | 1.3 (−5.3 to 7.9) | 0.2 (−0.7 to 1.1) | |
| Obesity | 39.7 (35.4 to 44.1) | −4.1 (−6.3 to −2.0) | −10.4 (−15.7 to −5.2) | −1.4 (−2.1 to −0.7) | |
| 60+ | Normal | 31.3 (26.5 to 36.4) | 1.7 (0.7 to 2.7) | 5.5 (2.0 to 8.9) | 0.3 (0.1 to 0.5) |
| Overweight | 42.1 (37.0 to 47.4) | −0.4 (−1.8 to 1.0) | −0.9 (−4.3 to 2.5) | −0.1 (−0.3 to 0.2) | |
| Obesity | 26.6 (22.5 to 31.3) | −1.3 (−2.3 to −0.4) | −5.0 (−8.6 to −1.3) | −0.2 (−0.4 to −0.1) | |
| Low | Normal | 37.9 (33.4 to 42.6) | 3.4 (1.8 to 5.0) | 8.9 (4.4 to 13.4) | 0.9 (0.5 to 1.3) |
| Overweight | 35.3 (31.1 to 39.7) | 1.4 (−1.8 to 4.7) | 4.1 (−5.3 to 13.4) | 0.4 (−0.5 to 1.3) | |
| Obesity | 26.8 (22.9 to 31.1) | −4.8 (−7.6 to −2.1) | −18.0 (−26.9 to −9.0) | −1.3 (−2.1 to −0.6) | |
| Middle | Normal | 30.6 (26.4 to 35.1) | 4.3 (2.2 to 6.5) | 14.2 (6.4 to 22.0) | 1.2 (0.6 to 1.8) |
| Overweight | 37.1 (33.0 to 41.4) | −1.2 (−4.1 to 1.6) | −3.3 (−10.9 to 4.2) | −0.3 (−1.1 to 0.4) | |
| Obesity | 32.3 (28.4 to 36.5) | −3.1 (−4.8 to −1.4) | −9.6 (−14.7 to −4.5) | −0.9 (−1.3 to −0.4) | |
| High | Normal | 24.8 (20.6 to 29.6) | 3.8 (2.3 to 5.4) | 15.4 (8.2 to 22.5) | 1.4 (0.8 to 2.0) |
| Overweight | 42.4 (37.7 to 47.3) | −0.1 (−2.5 to 2.3) | −0.2 (−5.9 to 5.5) | 0.0 (−0.9 to 0.9) | |
| Obesity | 32.7 (28.5 to 37.2) | −3.7 (−5.5 to −2.0) | −11.4 (−16.5 to −6.3) | −1.4 (−2.0 to −0.7) | |
pp to reflect the absolute difference.
“Normal” includes underweight <18.5 kg/m2.
Abbreviations: pp, percentage points; SES, socioeconomic status; SSB, sugar-sweetened beverage.
Fig 1Sensitivity analysis for estimated weight change after 12 years proposing different sugar reductions and different compensation rates.
SSB, sugar-sweetened beverage.